# Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

> **NCT07493447** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Eben Rosenthal** · enrollment: 30 (estimated)

## Conditions studied

- Meningioma
- Glioblastoma
- Acoustic Neuroma
- Brain Cancer
- Pituitary Adenoma

## Interventions

- **DRUG:** Panitumumab-IRDye800

## Key facts

- **NCT ID:** NCT07493447
- **Lead sponsor:** Eben Rosenthal
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-02
- **Primary completion:** 2030-05-02
- **Final completion:** 2031-06-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07493447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07493447, "Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07493447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*